Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Disclosed planOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 1 of the 13 calendar months from Oct 2025 to Oct 2026: Apr 2026.
- Largest single sale: $115K (2,367 shares) of Kiniksa Pharmaceuticals International, plc on Apr 6, 2026. Filing
- Last sale before this period: Sep 4, 2025.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Kiniksa Pharmaceuticals International, plc (KNSA) | Chief Operating Officer | Apr 15, 2021 | Sep 3, 2026 |
Recent filings
The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Sep 1, 2026, Kiniksa Pharmaceuticals International, plc: 8,285 shares vested; 4,007 shares withheld by the company for taxes. 1 filing: 1
- Apr 9, 2026, Kiniksa Pharmaceuticals International, plc: sold 1,703 shares for $80K, under a disclosed plan. 1 filing: 1
- Apr 7, 2026, Kiniksa Pharmaceuticals International, plc: 2,477 shares vested; 774 shares withheld by the company for taxes. 1 filing: 1
- Apr 6, 2026, Kiniksa Pharmaceuticals International, plc: sold 2,367 shares for $115K, under a disclosed plan. 1 filing: 1
- Apr 1, 2026, Kiniksa Pharmaceuticals International, plc: 5,808 shares vested; 1,706 shares withheld by the company for taxes. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.